St. Jude Medical Updates Optim Lead Registry Data and Status of Riata Leads Study in Bi-Annual Product Performance Report

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today released its bi-annual product performance report (PPR) on its website, sjmprofessional.com. The PPR updates the performance of all the company’s cardiac rhythm management devices, including actively-monitored registry data that supports the safety and reliability of the current-generation Durata® lead with Optim® insulation. The report also provides a new, expanded analysis specifically addressing the performance of the company’s high-voltage leads.
MORE ON THIS TOPIC